A new report from the Lown Institute finds that U.S. hospitals performed more than 229,000 unnecessary stents on Medicare patients from 2019-2021. Here's what overuse experts had to say about the issue... More
As private equity’s infiltration into cardiology expands, what does this mean for the cost and quality of care? More
What's the evidence behind PCI, and why do hospitals keep doing these procedures? We revisit this issue with a look back at research and interviews over last few years to give you the answers. More
A recent study finds that medical device companies spend more than pharma on payments to physicians, but spend it in different ways. More
Does receiving money from medical device companies impact the devices doctors implant in patients? A recent study in JAMA suggests that it does. More
Many cardiologists recognize that placing coronary stents for stable heart disease has limited clinical benefit for patients. But low-value stents are still common -- how can we change this practice? New research in JAMA Internal Medicine provides some suggestions. More
A potential silver lining of the COVID-19 pandemic? An opportunity to permanently stop doing unnecessary elective procedures. More
In a recent Washington Post op-ed, Shannon Brownlee and Jeanne Lenzer explain why the FDA's proposed changes are unlikely to make a real difference in medical device safety. More
If you thought the only takeaway from ORBITA was "stents don't work," you're missing the point, says Dr. Vikas Saini in Health Affairs. More
The ORBITA debate continues as the study authors respond to critical letters in The Lancet. More
Catheter ablation for atrial fibrillation has been used for 20 years, and grown into a $4.5 billion industry. But is the procedure actually effective? More
Professor Doug McKell explains why ORBITA might not be enough to reduce unnecessary stents. More
Cardiologist David Brown addresses some of the criticisms of the controversial ORBITA trial. More
A study in The Lancet this week has rocked the world of cardiology by showing that stents are no better than a placebo in relieving chest pain. More